Language:
English
繁體中文
Help
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Nanoparticles for Rational Vaccine D...
~
Gill, Harvinder Singh.
Nanoparticles for Rational Vaccine Design
Record Type:
Language materials, printed : Monograph/item
Title/Author:
Nanoparticles for Rational Vaccine Design/ edited by Harvinder Singh Gill, Richard W. Compans.
other author:
Gill, Harvinder Singh.
Description:
VII, 130 p. 26 illus., 11 illus. in color.online resource. :
Contained By:
Springer Nature eBook
Subject:
Vaccines. -
Online resource:
https://doi.org/10.1007/978-3-030-85067-8
ISBN:
9783030850678
Nanoparticles for Rational Vaccine Design
Nanoparticles for Rational Vaccine Design
[electronic resource] /edited by Harvinder Singh Gill, Richard W. Compans. - 1st ed. 2021. - VII, 130 p. 26 illus., 11 illus. in color.online resource. - Current Topics in Microbiology and Immunology,4332196-9965 ;. - Current Topics in Microbiology and Immunology,387.
Preface -- Liposome Formulations as Adjuvants for Vaccines -- Polymeric nanoparticle-based vaccine adjuvants and delivery vehicles -- Virus-like particle vaccines against respiratory viruses and protozoan parasites -- Protein and Peptide Nanocluster Vaccines.
This book introduces nanoparticles as a powerful platform for vaccine design. Current challenges in vaccine development are discussed and the unique advantages nanoparticles provide in overcoming these challenges are explored. The authors offer fascinating insights into the immunological assets of using nanoparticles as delivery vehicles or adjuvants and present different materials that are being used in nanoparticle-based vaccine development, covering peptides, proteins, polymers, virus-like particles, and liposomes. Its contemporary research insights and practical examples for applications make this volume an inspiring read for researchers and clinicians in vaccinology and immunology. Chapter "Liposome Formulations as Adjuvants for Vaccines" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
ISBN: 9783030850678
Standard No.: 10.1007/978-3-030-85067-8doiSubjects--Topical Terms:
582184
Vaccines.
LC Class. No.: RM281
Dewey Class. No.: 615.372
Nanoparticles for Rational Vaccine Design
LDR
:02617nam a22004215i 4500
001
1048136
003
DE-He213
005
20210830085155.0
007
cr nn 008mamaa
008
220103s2021 sz | s |||| 0|eng d
020
$a
9783030850678
$9
978-3-030-85067-8
024
7
$a
10.1007/978-3-030-85067-8
$2
doi
035
$a
978-3-030-85067-8
050
4
$a
RM281
050
4
$a
QR189-189.5
072
7
$a
MJCM
$2
bicssc
072
7
$a
MED044000
$2
bisacsh
072
7
$a
MJCM
$2
thema
082
0 4
$a
615.372
$2
23
245
1 0
$a
Nanoparticles for Rational Vaccine Design
$h
[electronic resource] /
$c
edited by Harvinder Singh Gill, Richard W. Compans.
250
$a
1st ed. 2021.
264
1
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2021.
300
$a
VII, 130 p. 26 illus., 11 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
490
1
$a
Current Topics in Microbiology and Immunology,
$x
2196-9965 ;
$v
433
505
0
$a
Preface -- Liposome Formulations as Adjuvants for Vaccines -- Polymeric nanoparticle-based vaccine adjuvants and delivery vehicles -- Virus-like particle vaccines against respiratory viruses and protozoan parasites -- Protein and Peptide Nanocluster Vaccines.
520
$a
This book introduces nanoparticles as a powerful platform for vaccine design. Current challenges in vaccine development are discussed and the unique advantages nanoparticles provide in overcoming these challenges are explored. The authors offer fascinating insights into the immunological assets of using nanoparticles as delivery vehicles or adjuvants and present different materials that are being used in nanoparticle-based vaccine development, covering peptides, proteins, polymers, virus-like particles, and liposomes. Its contemporary research insights and practical examples for applications make this volume an inspiring read for researchers and clinicians in vaccinology and immunology. Chapter "Liposome Formulations as Adjuvants for Vaccines" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
650
0
$a
Vaccines.
$3
582184
650
0
$a
Human physiology.
$3
636012
650
0
$a
Nanochemistry.
$3
596891
650
0
$a
Virology.
$3
644995
650
1 4
$a
Vaccine.
$3
782685
650
2 4
$a
Human Physiology.
$3
668349
700
1
$a
Gill, Harvinder Singh.
$e
editor.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1351948
700
1
$a
Compans, Richard W.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
793163
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9783030850661
776
0 8
$i
Printed edition:
$z
9783030850685
776
0 8
$i
Printed edition:
$z
9783030850692
830
0
$a
Current Topics in Microbiology and Immunology,
$x
0070-217X ;
$v
387
$3
1254330
856
4 0
$u
https://doi.org/10.1007/978-3-030-85067-8
912
$a
ZDB-2-SBL
912
$a
ZDB-2-SXB
950
$a
Biomedical and Life Sciences (SpringerNature-11642)
950
$a
Biomedical and Life Sciences (R0) (SpringerNature-43708)
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login